Evidence map›Paper›PMID 34324514›Full record

ArticlePloS one2021

Trends in COVID-19 cases and clinical management in Veterans Health Administration medical facilities: A national cohort study.

Maya Aboumrad, Brian Shiner, Natalie Riblet, Hugh Huizenga, Nabin Neupane, Yinong Young-Xu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Maya AboumradWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, United States of America.ORCID 0000-0001-6140-4250
Brian ShinerWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, United States of America.
Natalie RibletWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, United States of America.
Hugh HuizengaWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, United States of America.
Nabin NeupaneWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, United States of America.
Yinong Young-XuWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, United States of America.
Dartmouth College · USWhite River Junction VA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe explored longitudinal trends in sociodemographic characteristics, reported symptoms, laboratory findings, pharmacological and non-pharmacological treatment, comorbidities, and 30-day in-hospital mortality among hospitalized patients with coronavirus disease 2019 (COVID-19).

methodsThis retrospective cohort study included patients diagnosed with COVID-19 in the United States Veterans Health Administration between 03/01/20 and 08/31/20 and followed until 09/30/20. We focused our analysis on patients that were subsequently hospitalized, and categorized them into groups based on the month of hospitalization. We summarized our findings through descriptive statistics. We used Cuzick's Trend Test to examine any differences in the distribution of our study variables across the six months.

resultsDuring our study period, we identified 43,267 patients with COVID-19. A total of 8,240 patients were hospitalized, and 13.1% (N = 1,081) died within 30 days of admission. Hospitalizations increased over time, but the proportion of patients that died consistently declined from 24.8% (N = 221/890) in March to 8.0% (N = 111/1,396) in August. Patients hospitalized in March compared to August were younger on average, mostly black, urban-dwelling, febrile and dyspneic. They also had a higher frequency of baseline comorbidities, including hypertension and diabetes, and were more likely to present with abnormal laboratory findings including low lymphocyte counts and elevated creatinine. Lastly, there was a decline from March to August in receipt of mechanical ventilation (31.4% to 13.1%) and hydroxychloroquine (55.3% to <1.0%), while treatment with dexamethasone (3.7% to 52.4%) and remdesivir (1.1% to 38.9%) increased.

conclusionAmong hospitalized patients with COVID-19, we observed a trend towards decreased disease severity and mortality over time.

Indexed as

Adenosine MonophosphateAgedAged, 80 and overAlanineComorbidityCOVID-19COVID-19 Drug TreatmentDexamethasoneFemaleHospitalizationHospital MortalityHumansLongitudinal StudiesLymphocyte CountLymphocytesMaleAdenosine MonophosphateAlanineDexamethasoneremdesivir

Identifiers

PMID34324514
PMCPMC8321215
OpenAlexW3183698504

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.